| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8247566 | International Journal of Radiation Oncology*Biology*Physics | 2006 | 6 Pages |
Abstract
Conclusions: The pattern of primary site failure within the target volume suggests locally advanced T stage disease may require a higher biologic dose to gross tumor. Rates of severe (Grade 3-4) ototoxicity and xerostomia are low with IMRT as a result of normal-tissue protection. Distant metastases are now the dominant form of failure, emphasizing the need for improved systemic therapy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Suzanne L. M.D., William C. B.S., David G. M.D., Dennis H. M.D., Sean L. B.S., Michael J. M.D.,